Santhi Gladson

1.0k total citations
25 papers, 742 citations indexed

About

Santhi Gladson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Santhi Gladson has authored 25 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Santhi Gladson's work include Pulmonary Hypertension Research and Treatments (22 papers), Bone health and treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Santhi Gladson is often cited by papers focused on Pulmonary Hypertension Research and Treatments (22 papers), Bone health and treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Santhi Gladson collaborates with scholars based in United States, Netherlands and China. Santhi Gladson's co-authors include James West, Anna R. Hemnes, James E. Loyd, Tom Blackwell, Eric D. Austin, Yuji Tada, Megha Talati, Rizwan Hamid, Toshio Suzuki and Kirk B. Lane and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Santhi Gladson

24 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Santhi Gladson United States	15	557	199	187	91	85	25	742
Nicholas Duggan United Kingdom	9	514 0.9×	217 1.1×	187 1.0×	83 0.9×	67 0.8×	16	709
Rintaro Nishimura Japan	14	360 0.6×	160 0.8×	172 0.9×	69 0.8×	51 0.6×	37	545
Andrea L. Frump United States	17	527 0.9×	173 0.9×	280 1.5×	74 0.8×	55 0.6×	35	706
Henrik ten Freyhaus Germany	17	383 0.7×	218 1.1×	295 1.6×	68 0.7×	61 0.7×	45	787
C.H. Sattler France	11	778 1.4×	197 1.0×	418 2.2×	99 1.1×	65 0.8×	22	986
Nobuhiro Yaoita Japan	18	566 1.0×	165 0.8×	439 2.3×	95 1.0×	63 0.7×	38	913
Chris Happé Netherlands	15	717 1.3×	208 1.0×	525 2.8×	100 1.1×	69 0.8×	21	941
Diana Zabini Austria	13	431 0.8×	185 0.9×	108 0.6×	66 0.7×	46 0.5×	19	621
B.A. McKeon United States	9	527 0.9×	368 1.8×	149 0.8×	96 1.1×	266 3.1×	13	832
Ewa Bieniek Poland	7	282 0.5×	119 0.6×	88 0.5×	81 0.9×	57 0.7×	13	421

Countries citing papers authored by Santhi Gladson

Since Specialization

Citations

This map shows the geographic impact of Santhi Gladson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santhi Gladson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santhi Gladson more than expected).

Fields of papers citing papers by Santhi Gladson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santhi Gladson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santhi Gladson. The network helps show where Santhi Gladson may publish in the future.

Co-authorship network of co-authors of Santhi Gladson

This figure shows the co-authorship network connecting the top 25 collaborators of Santhi Gladson. A scholar is included among the top collaborators of Santhi Gladson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santhi Gladson. Santhi Gladson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jingyuan, Xinping Chen, Vineet Agrawal, et al.. (2025). Estrogen and Cyp1b1 Regulate Pparγ in Pulmonary Hypertension Through a Ubiquitin‐Dependent Mechanism. Pulmonary Circulation. 15(1). e70054–e70054.

Bender, Aaron M., Sheila Shay, Santhi Gladson, et al.. (2023). Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension. JACC Basic to Translational Science. 8(10). 1379–1388. 6 indexed citations

Shay, Sheila, et al.. (2020). Amino Acid Complexed Zinc Has Higher Bioavailability Than Hydroxy Acid Complexed Zinc. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

Rathinasabapathy, Anandharajan, Erica J. Carrier, Sheila Shay, et al.. (2020). Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension. Frontiers in Medicine. 7. 540–540. 4 indexed citations

West, James, Xinping Chen, Yan Ling, et al.. (2019). Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension. Pulmonary Circulation. 10(1). 1–11. 11 indexed citations

Rathinasabapathy, Anandharajan, Alana Horowitz, Ashok Kumar, et al.. (2018). The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury. Frontiers in Physiology. 9. 180–180. 51 indexed citations

Rathinasabapathy, Anandharajan, Andrew J. Bryant, Toshio Suzuki, et al.. (2018). rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling. Frontiers in Physiology. 9. 271–271. 22 indexed citations

Pickworth, Josephine, Alexander Rothman, James Iremonger, et al.. (2017). Differential IL‐1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling. Pulmonary Circulation. 7(4). 768–776. 20 indexed citations

Suzuki, Toshio, Yuji Tada, Santhi Gladson, et al.. (2017). Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respiratory Research. 18(1). 177–177. 105 indexed citations

10.

Talati, Megha, Santhi Gladson, Tom Blackwell, et al.. (2016). Macrophages are part of cause, not consequence, in PAH. The FASEB Journal. 30(S1). 2 indexed citations

11.

West, James, Erica J. Carrier, Nathaniel Bloodworth, et al.. (2016). Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension. PLoS ONE. 11(2). e0148657–e0148657. 36 indexed citations

12.

Lu, Yan, Megha Talati, Santhi Gladson, et al.. (2015). Bone Marrow-derived Cells Contribute to Pathogenesis of Pulmonary Arterial Hypertension.. American Journal of Respiratory and Critical Care Medicine. 2 indexed citations

13.

Ling, Yan, Xinping Chen, Megha Talati, et al.. (2015). Bone Marrow–derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 193(8). 898–909. 53 indexed citations

14.

Chen, Xinping, Megha Talati, Joshua P. Fessel, et al.. (2015). Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism. Circulation. 133(1). 82–97. 79 indexed citations

15.

Bryant, Andrew J., Linda Robinson, Thomas R. Blackwell, et al.. (2015). Expression of Mutant Bone Morphogenetic Protein Receptor II Worsens Pulmonary Hypertension Secondary to Pulmonary Fibrosis. Pulmonary Circulation. 5(4). 681–690. 27 indexed citations

16.

Fessel, Joshua P., Charles R. Flynn, Linda Robinson, et al.. (2013). Hyperoxia Synergizes with Mutant Bone Morphogenic Protein Receptor 2 to Cause Metabolic Stress, Oxidant Injury, and Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 49(5). 778–787. 34 indexed citations

17.

Fessel, Joshua P., Xinping Chen, Andrea L. Frump, et al.. (2013). Interaction between Bone Morphogenetic Protein Receptor Type 2 and Estrogenic Compounds in Pulmonary Arterial Hypertension. Pulmonary Circulation. 3(3). 564–577. 42 indexed citations

18.

Austin, Eric D., Rizwan Hamid, Anna R. Hemnes, et al.. (2012). BMPR2 expression is suppressed by signaling through the estrogen receptor. Biology of Sex Differences. 3(1). 6–6. 90 indexed citations

19.

Johnson, Jennifer, Anna R. Hemnes, Kirk B. Lane, et al.. (2010). Olmesartan Does Not Treat Pulmonary Arterial Hypertension In BMPR2R899X Mice. A6326–A6326. 2 indexed citations

20.

Majka, Susan M., Margaret C. Skokan, Julie W. Harral, et al.. (2008). Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 295(6). L1028–L1039. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact